Obagi Medical Products Company Profile (NASDAQ:OMPI)

About Obagi Medical Products (NASDAQ:OMPI)

Obagi Medical Products logoObagi Medical Products, Inc. (Obagi) is a specialty pharmaceutical company that develops, markets and sells, and is a provider of, topical aesthetic and therapeutic prescription-strength skin care systems and related products in the physician-dispensed market. Obagi systems and products are designed to prevent and improve the common and visible skin disorders in adult skin, including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, facial redness, and soft tissue deficits, such as fine lines and wrinkles. Obagi sells its products through a direct sales force in the United States and internationally through distribution partners in over 43 countries across North America, Central America, Europe, the Middle East and Asia. In April 2013, Valeant Pharmaceuticals International Inc acquired the entire share capital of Obagi Medical Products Inc.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:OMPI
  • CUSIP: N/A
  • Web: N/A
P/E:
  • Trailing P/E Ratio:
  • P/E Growth:
Dividend:
  • Dividend Yield: 1.0%
 
Frequently Asked Questions for Obagi Medical Products (NASDAQ:OMPI)

What is Obagi Medical Products' stock symbol?

Obagi Medical Products trades on the NASDAQ under the ticker symbol "OMPI."

Who are some of Obagi Medical Products' key competitors?

How do I buy Obagi Medical Products stock?

Shares of Obagi Medical Products can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Obagi Medical Products' stock price today?

One share of Obagi Medical Products stock can currently be purchased for approximately $23.98.


MarketBeat Community Rating for Obagi Medical Products (NASDAQ OMPI)
Community Ranking:  2.4 out of 5 ( )
Outperform Votes:  35 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about Obagi Medical Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Obagi Medical Products (NASDAQ:OMPI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Obagi Medical Products (NASDAQ:OMPI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Obagi Medical Products (NASDAQ:OMPI)
Earnings by Quarter for Obagi Medical Products (NASDAQ:OMPI)
Earnings History by Quarter for Obagi Medical Products (NASDAQ OMPI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/14/2013Q4 2012$0.21$0.15$30.06 million$30.30 millionViewListenView Earnings Details
11/1/2012Q312$0.20$0.22$28.87 million$29.10 millionViewN/AView Earnings Details
8/2/2012$0.20$0.22ViewN/AView Earnings Details
5/3/2012$0.21$0.16ViewN/AView Earnings Details
3/8/2012$0.19$0.27ViewN/AView Earnings Details
11/9/2011$0.17$0.24ViewN/AView Earnings Details
8/4/2011$0.16$0.18ViewN/AView Earnings Details
5/5/2011$0.13$0.16ViewN/AView Earnings Details
3/10/2011$0.09$0.14ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Obagi Medical Products (NASDAQ:OMPI)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Obagi Medical Products (NASDAQ:OMPI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Obagi Medical Products (NASDAQ:OMPI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Obagi Medical Products (NASDAQ:OMPI)
Latest Headlines for Obagi Medical Products (NASDAQ:OMPI)
Source:
No headlines for this company have been tracked by MarketBeat.com

Social

Chart

Obagi Medical Products (OMPI) Chart for Wednesday, July, 26, 2017

This page was last updated on 7/26/2017 by MarketBeat.com Staff